Bladder Cancer Clinical Trial

Determinants of Bladder Cancer Recurrence Study (The DETER Study)

Summary

The purpose of this study is to learn how different lifestyle factors, such as cigarette smoking and body weight, change after a diagnosis of bladder cancer, and how they influence who gets a bladder cancer recurrence and who does not.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients ≥18 years old AND
Histologically-confirmed non-muscle invasive bladder cancer (NMIBC)

Exclusion Criteria:

Patients are ineligible for the study if they have/had:
Histologically-confirmed NMIBC diagnosed >36 months prior to enrollment
Cystectomy prior to enrollment
Any condition, which in the opinion of the primary MSK clinician or investigators precludes their ability to provide informed consent or comply with study procedures
Non English-speaking

Study is for people with:

Bladder Cancer

Estimated Enrollment:

600

Study ID:

NCT02400944

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
Basking Ridge New Jersey, , United States
Memorial Sloan Kettering Commack
Commack New York, 11725, United States
Memorial Sloan Kettering Westchester
Harrison New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

600

Study ID:

NCT02400944

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.